Evidence map›Paper›PMID 39366745›Full record

Trial reportSexually transmitted infections2025

Effect of antenatal

Aamirah Mussa, Adriane Wynn, Rebecca Ryan, Chibuzor M Babalola, Emily Hansman, Selebaleng Simon, Bame Bame, Neo Moshashane, Maitumelo Masole, Melissa L Wilson and 2 more

Registry-linked trialAbstract readClinical TrialMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Sexually transmitted infections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04955717 (The Diagnosis and Treatment of Chlamydia Trachomatis and Neisseria Gonorrhoeae in Pregnant Women to Prevent Adverse Neonatal Consequences.), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04955717 nacompletednot on this map

The Diagnosis and Treatment of Chlamydia Trachomatis and Neisseria Gonorrhoeae in Pregnant Women to Prevent Adverse Neonatal Consequences.

TypeinterventionalSponsorUniversity of Southern CaliforniaRan2021 to 2023Enrolled500ConditionsChlamydia Trachomatis Infection, Neonatal Infection, Preterm Birth, GonorrheaArmsChlamydia trachomatis and Neisseria gonorrhoeae screening using the GeneXpert
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Aamirah MussaBotswana Harvard Health Partnership, Gaborone, Botswana aamirahmussa@gmail.com.ORCID 0000-0001-9152-5686
Adriane WynnUniversity of California San Diego, La Jolla, California, USA.
Rebecca RyanBotswana Harvard Health Partnership, Gaborone, Botswana.
Chibuzor M BabalolaUniversity of Southern California Keck School of Medicine, Los Angeles, California, USA.
Emily HansmanUniversity of California Los Angeles, Los Angeles, California, USA.ORCID 0000-0002-9375-8675
Selebaleng SimonBotswana Harvard Health Partnership, Gaborone, Botswana.
Bame BameBotswana Harvard Health Partnership, Gaborone, Botswana.
Neo MoshashaneBotswana Harvard Health Partnership, Gaborone, Botswana.
Maitumelo MasoleBotswana Harvard Health Partnership, Gaborone, Botswana.
Melissa L WilsonUniversity of Southern California Keck School of Medicine, Los Angeles, California, USA.
Jeffrey D KlausnerUniversity of Southern California Keck School of Medicine, Los Angeles, California, USA.
Chelsea MorroniBotswana Harvard Health Partnership, Gaborone, Botswana.

Funding

Training in HIV Genomics, Treatment, and Cure Research in BotswanaD43TW009610 · FIC · THE BOTSWANA HARVARD HEALTH PARTNERSHIP · PI SHAHIN LOCKMAN, Joseph Moeketsi Makhema · 2013 to 2026
$4.4M
Modeling reductions in harmful alcohol use on HIV transmission and mortality in the era of universal test and treat in UgandaK01AA027733 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WYNN, ADRIANE MICHELLE · 2020 to 2024
$888k
The diagnosis and treatment of Chlamydia trachomatis and Neisseria gonorrhoeae in pregnant women to prevent adverse neonatal consequencesR21HD100821 · NICHD · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KLAUSNER, JEFFREY DAVID, MORRONI, CHELSEA · 2020 to 2021
$398k
FIC NIH HHS D43 TW009610NIAAA NIH HHS K01 AA027733NICHD NIH HHS R21 HD100821
6 · The paper itself

Abstract

objectives

methodsThe Maduo Study was a non-randomised cluster crossover trial in Botswana to provide preliminary data on the effect of antenatal

resultsThe study enrolled 500 women; 206 (82.1%) and 187 (75.1%) were retained in the intervention and standard-of-care arms, respectively and screened ≤12 weeks postdelivery.

conclusionsPostdelivery prevalence of TRIAL REGISTRATION NUMBER: NCT04955717.

Indexed as

Chlamydia InfectionsChlamydia trachomatisGonorrheaInfectious Disease Transmission, VerticalPregnancy Complications, InfectiousAdultBotswanaCross-Over StudiesFemaleHumansInfant, NewbornMass ScreeningNeisseria gonorrhoeaePregnancyPrenatal CarePrenatal DiagnosisAfricaantenatal carechlamydia infectionsgonorrhoeapregnancy

Identifiers

PMID39366745
PMCPMC11932793

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.